当前位置：首页 > 文献互助 > 互助详情

OWL833, an Orally Active Nonpeptide GLP-1 Receptor Agonist, Improves Glucose Tolerance by Increasing Insulin Secretion and Reduces Food Intake of Cynomolgus Monkeys复制

用户iFJlr3_29a30 1小时前 6 10 求助中 帖子自动结束时间: 2026-08-22 11:20:28

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.2337/db18-1118-p复制

文献链接: https://diabetesjournals.org/diabetes/article/67/Supplement_1/1118-P/54121/OWL833-an-Orally-Active-Nonpeptide-GLP-1-Receptor复制

其他信息:

出版社: American Diabetes Association
作者: TAKAHIRO KAWAI; FUMIHITO TANINO; MASANORI FUKAZAWA; KOTARO OGAWA; SHUNSUKE NAGAO; HITOSHI YOSHINO; SHUN-ICHIRO KOMATSU; YOSHIYUKI SUZUKI; YOSHIKI KAWABE
全文下载地址: https://diabetesjournals.org/diabetes/article/67/Supplement_1/1118-P/54121/OWL833-an-Orally-Active-Nonpeptide-GLP-1-Receptor

上一篇：Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris

下一篇：Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma.

互助时间线

2026-08-17 11:20:28 [发起求助]

最新发布的求助

Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma. 1小时前
OWL833, an Orally Active Nonpeptide GLP-1 Receptor Agonist, Improves Glucose Tolerance by Increasing Insulin Secretion and Reduces Food Intake of Cynomolgus Monkeys 1小时前
Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris 1小时前
A Gram-Scale Synthesis of Enantiomerically Pure (R)- and (S)-δ-Heptalactone, Pheromones of Fruit Flies 1小时前
Discovery of co-stimulatory anti-CD28 VHHs for developing cancer immune therapeutic anti-tumor/CD3/CD28 trispecific T cell engager 1小时前
Total Pancreatectomy and Islet Autotransplantation for Chronic Pancreatitis: Breaking Down Barriers 1小时前
Study on the aerogel cement-based composites for geothermal insulation cementing 2小时前
Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study 2小时前
Aqueous Humor and the Dynamics of Its Flow: Mechanisms and Routes of Aqueous Humor Drainage 2小时前
What next? Sustaining anti-obesity pharmacotherapy success through metabolic maintenance 2小时前
Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions. 2小时前
Artificial intelligence in drug discovery — what it is, where we stand and the path forward 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com